OptiBiotix inks ingredient deal with Tata Chemicals

Life sciences developer OptiBiotix Health announced a significant agreement with Tata Chemicals on Monday, that would see its proprietary ‘Fossence’ product incorporated into their ‘SlimBiome’ and ‘LeanBiome’ product lines, specifically tailored for the Indian market.

The AIM-traded firm said the deal would see Tata's Fossence - a proprietary short chain fructo-oligosaccharide (FOS) - into OptiBiotix's SlimBiome and LeanBiome products, customised to cater to the demands of the Indian consumer base.

It said Fossence would directly replace the FOS currently used in SlimBiome products available in other markets.

The board said the integration was a strategic move grounded in scientific substantiation, aiming to bring forth the well-documented health benefits of FOS to the Indian market.

It said Tata Chemicals, listed on the Indian stock exchange, is an integral part of the Tata Group, which employs over one million people and recorded annual revenue of around $300bn in 2022.

As part of the collaboration, Tata Chemicals granted approval for the incorporation of the Fossence logo on products containing SlimBiome in India, introducing a branded ingredient from a reputable source to Indian consumers.

“We are pleased to report this agreement with Tata Chemicals which creates the opportunity to bring products containing Tata’s proprietary Fossence in SlimBiome and LeanBiome to the Indian market,” said chief executive officer Stephen O'Hara.

“Tata Chemicals is one of India's leading suppliers of food ingredients with many well-known and respected brands.

“Fossence's established health benefits with Indian consumers and its trusted brand combined with SlimBiome's strong science, clinical studies, and excellent customer reviews will help reduce hunger and food cravings to support the weight management efforts of India's 135 million obese men and women.”

Reporting by Josh White for Sharecast.com.